MedPath

A clinical study to study the drug Munnai ilai kudineer on vatham

Phase 2
Not yet recruiting
Conditions
Thandaga Vatham
Registration Number
CTRI/2018/04/012990
Lead Sponsor
Dr R Neelavathy
Brief Summary

The Study is A prospective open labelled phase II non randomized clinical trial to evaluate the therapeutic efficacy of munnai ilai kudineer for the treatment of Thandaga Vatham 30ml daily twice time per day for 30 days in 40 patients during the trial period of 18 months that will be conducted in government siddha medical college and hospital palayamkottai tirunelveli tamilnadu the primary out come will be the therpeutic efficacy of trial drug munnai ilai kudineer on Thandaga Vatham The Secondary outcome will be the evaluation of siddha diagnostic parameters

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients with low back pain with radiography of lumbosacral spine showing Loss of natural lumbar lordosis Reduction in disc space Osteoporosis Subluxation of vertebra.

Exclusion Criteria

Diabetes mellitus Auto immune diseases like sle Chronic kidney disease Fracture of Spine Tuberculosis of spine Congenital spino vertebral deformities Cardiac disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The therapeutic efficacy of trial drug munnai ilai kudineer on Thandaga Vatham30 days
Secondary Outcome Measures
NameTimeMethod
Evaluation of Siddha diagnostic parametes30 days

Trial Locations

Locations (1)

Government Siddha Medical College

🇮🇳

Tirunelveli, TAMIL NADU, India

Government Siddha Medical College
🇮🇳Tirunelveli, TAMIL NADU, India
Dr N Prakash
Principal investigator
9578563300
drprakashbsms@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.